Carolyn Sueprofile image
Professor

Carolyn Sue AM


Current Appointments

Kinghorn Chair, Neurodegeneration
Deputy Director, Translation and Impact Capability
email hidden; JavaScript is required

Professor Carolyn Sue, AM, MBBS, PhD, FRACP, holds the prestigious Kinghorn Chair of Neurodegeneration at Neuroscience Research Australia (NeuRA), is a Professor of Neurology at the University of New South Wales (UNSW) and Director of Neurosciences at Prince of Wales Hospital (POWH). An internationally recognised clinician-scientist, Professor Sue is renowned for her pioneering research in Parkinson's disease and mitochondrial disorders. She leads the Australian Mitochondrial Disease Centre and the Parkinson’s Disease Centre of Excellence at NeuRA and has significantly advanced the understanding of neurodegenerative diseases through her innovative research integrating genomics, molecular neuroscience, and adult stem cell models.
 
As the immediate past Executive Director of the Kolling Institute, she has established a legacy of translational research excellence. Professor Sue’s research has resulted in the discovery of several key disease genes and new diagnostic approaches, with over 200 peer-reviewed publications and numerous accolades, including the Member of the Order of Australia for her services to medicine. She also holds multiple leadership roles, including President of the Movement Disorder Society of Australia and New Zealand and Council Member of the National Health and Medical Research Council (NHMRC). Her work continues to shape the future of medical research and patient care in neurodegenerative diseases.

For clinic enquiries, please email email hidden; JavaScript is required


Publications

2024 Jan

The pathogenesis of Parkinson's disease.

View full journal-article on http://europepmc.org/abstract/med/38245249

2023 Oct

Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene.

View full journal-article on http://europepmc.org/abstract/med/37890334

2023 Sep

Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review.

View full journal-article on http://europepmc.org/abstract/med/37761896

2023 Sep

Pharmacological rescue of mitochondrial and neuronal defects in <i>SPG7</i> hereditary spastic paraplegia patient neurons using high throughput assays.

View full journal-article on http://europepmc.org/abstract/med/37766787

2023 Jul

Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson's disease.

View full journal-article on http://europepmc.org/abstract/med/37443150

2023 Jun

Generation of human-induced pluripotent-stem-cell-derived cortical neurons for high-throughput imaging of neurite morphology and neuron maturation.

View full journal-article on http://europepmc.org/abstract/med/37300830

2023 Jun

Genetic Testing in Parkinson's Disease.

View full journal-article on http://europepmc.org/abstract/med/37365908

2023 Jun

International Genetic Testing and Counseling Practices for Parkinson's Disease.

View full journal-article on http://europepmc.org/abstract/med/37310233

2023 May

Healthcare resource utilization of patients with mitochondrial disease in an outpatient hospital setting.

View full journal-article on http://europepmc.org/abstract/med/37246228

2023 Mar

NEMoE: a nutrition aware regularized mixture of experts model to identify heterogeneous diet-microbiome-host health interactions.

View full journal-article on http://europepmc.org/abstract/med/36918961